TVGN - קפיטליזציית שוק Tevogen Bio Holdings, Inc.

Tevogen Bio Holdings (TVGN) is developing cell therapy by implementing AI models and automation to optimize drug creation. This price action chart below demonstrates assets at the level of 0.03. The business relies on robotic T-cell cultivation to reduce costs, however, the company is facing an acute liquidity shortage due to expensive trials in the absence of current revenue.

Market capitalization determines the total value of all an issuer's shares, serving as a fundamental measure of business scale. This metric is calculated as the product of the current share price and the total number of outstanding securities. By analyzing the dynamics of a company's market value, an investor assesses the market consensus regarding the asset's prospects. For Tevogen Bio Holdings (TVGN), this reflects market expectations for clinical trials. The absence of stable revenue makes this indicator sensitive to news regarding capital raising.